» Articles » PMID: 10976001

An IL-6/IL-6 Soluble Receptor (IL-6R) Hybrid Protein (H-IL-6) Induces EPO-independent Erythroid Differentiation in Human CD34(+) Cells

Overview
Journal Cytokine
Date 2000 Sep 8
PMID 10976001
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

H-IL-6 is a hybrid protein constructed to contain IL-6 and its soluble receptor linked by a flexible peptide chain. Here we show that H-IL-6 strongly enhances proliferation of human CD34(+)cells in serum-free liquid culture, and that the majority of the cells generated belong to the erythroid lineage, being positive for the marker Glycophorin A. Conversely, H-IL-6 does not increase the number of myeloid, CD13-positive cells. Comparable effects are observed on progenitors from cord blood and adult peripheral blood. Therefore, H-IL-6 triggers an erythroid-inducing signal in haematopoietic progenitor cells, independently from erythropoietin (EPO).

Citing Articles

Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitors.

Yamamura K, Ohishi K, Katayama N, Kato K, Shibasaki T, Sugimoto Y Cancer Sci. 2007; 98(10):1597-603.

PMID: 17645774 PMC: 11158033. DOI: 10.1111/j.1349-7006.2007.00566.x.